Rui Avelar
Chief Tech/Sci/R&D Officer at EVOLUS, INC.
Net worth: 4 M $ as of 2024-04-29
Rui Avelar active positions
| Companies | Position | Start | End |
|---|---|---|---|
| EVOLUS, INC. | Chief Tech/Sci/R&D Officer | 2013-12-31 | - |
Career history of Rui Avelar
Former positions of Rui Avelar
| Companies | Position | Start | End |
|---|---|---|---|
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Chief Tech/Sci/R&D Officer | 2013-12-31 | 2018-01-31 |
| Allergan Medical Optics | Chief Tech/Sci/R&D Officer | 2011-02-28 | 2013-11-30 |
Training of Rui Avelar
| University of Toronto | Doctorate Degree |
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| EVOLUS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
| Allergan Medical Optics |
- Stock Market
- Insiders
- Rui Avelar
- Experience
